MedPath

Study Examining the Effect of Exercise in People With Rheumatoid Arthritis Taking Anti-TNFalpha Medication

Phase 2
Conditions
Arthritis, Rheumatoid
Interventions
Other: Gym exercise group intervention
Other: Hydrotherapy group exercise intervention
Other: Control group
Registration Number
NCT00855322
Lead Sponsor
University College Dublin
Brief Summary

The purpose of this study is to determine whether exercise is beneficial for people with rheumatoid arthritis(RA) taking antiTNFalpha medication

Detailed Description

Substantial progress has been made in the medical management of RA over the past decade but at present no drug therapy leads to long-term remission for all patients with RA. People may still continue to experience physical, psychological and functional consequences which could benefit from rehabilitation.little research exists on the effects of exercise for people with RA taking anti-TNFalpha therapy medication.

It is proposed to conduct a randomized controlled trial to examine the effects of group exercise therapy in a gym setting or in a hydrotherapy pool compared to a control group.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Patients with RA receiving anti-TNFalpha therapy medication for more than three months
  • Consenting male and female patients aged 18 - 70 years
  • Patients will have a documented diagnosis of RA as classified by the American College of Rheumatology (ACR) criteria
  • ACR functional class I, II, III
Exclusion Criteria
  • Patients who have attended physiotherapy in the past three months
  • Patients to whom exercise therapy or hydrotherapy are contraindicated
  • Patients who have undergone joint surgery in the past six months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Gym exercise group interventionGym group exercise intervention
2Hydrotherapy group exercise interventionHydrotherapy group exercise intervention
3Control groupControl group
Primary Outcome Measures
NameTimeMethod
Stanford Health Assessment QuestionnaireBaseline, 8 weeks and 24 weeks
Secondary Outcome Measures
NameTimeMethod
50 foot Walk TestBaseline, 8 weeks and 24 weeks

Trial Locations

Locations (1)

Our Lady's Hospice

🇮🇪

Dublin, Ireland

© Copyright 2025. All Rights Reserved by MedPath